
Avalyn Pharma
Operator of a clinical-stage biopharmaceutical company intended for the treatment of idiopathic pulmonary fibrosis and severe respiratory diseases. The company engages in the creation of an inhaled fo...
Valuation
$0
Share Price
N/A
Total Raised
$386.7M
Last Round
N/A